Inhibitory effects of transforming growth factor-beta (TGF-β) on certain functions of intraepithelial lymphocytes

Clinical and Experimental Immunology

Volumn 115, Issue 3, 1999, Pages 415-420

  Ebert, Ellen C ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

IL 15; IL 2; IL 7; Intraepithelial lymphocytes; Lamina propria lymphocytes; Mucosal immunity; Natural killer cells

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD56 ANTIGEN; CYTOKINE ANTIBODY; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7; LYMPHOKINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; JEJUNUM MUCOSA; LEUKOCYTE ADHERENCE; LYMPHOCYTE ACTIVATION; LYMPHOKINE ACTIVATED KILLER CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD2; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOTOXICITY, IMMUNOLOGIC; EPITHELIAL CELLS; HUMANS; INTEGRINS; INTERLEUKIN-2; INTERLEUKIN-7; JEJUNUM; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033030517     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00824.x     Document Type: Article

References (30)

1. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Eng J Med 1994; 331:1286-92.
2. Mule JJ, Schwarz SL, Roberts AB, Sporn MB, Rosenberg SA. Transforming growth factor-beta inhibits the in vitro generation of lympho-kine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunoother 1988; 26:95.
3. Bellone G, Aste-Amezaga M, Trinchieri G, Rodeck U. Regulation of NK cell functions by TGFβ1. J Immunol 1995; 155:1066-73.
4. Ahuja SS, Palioginnni F, Yamada H, Balow JE, Boumpas DT. Effects of transforming growth factor-β on early and late activation events in human T cells. J Immunol 1993; 150:3109-18.
5. + T cells. J Immunol 1995; 155:609-18.
6. Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD. Immuno-modulatory effects of transforming growth factor-βon T lymphocytes: induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. J Immunol 1992; 148:3847-56.
7. Cerwenka A, Beret D, Majdic O, Knapp W, Halter W. TGF-β1 is a potent inducer of human effector T cells. J lmmunol 1994; 153:4367-77.
8. Kondo S, Isobe K, Ishiguro N, Nakashima I, Miura T. Transforming growth factor-β1 enhances the generation of allospecific cytotoxic T lymphocytes. Immunology 1993; 79:459-64.
9. Van Den Wall Bake A, Black K, Kulhavy R, Mestccky J, Jackson S. Transforming growth factor-β inhibits the production of IgG, IgM, and IgA in human lymphocyte cultures. Cell Immunol 1992; 144:417-28.
10. E on lymphocytes is not associated with mucosa-specific homing. Eur J Immunol 1995; 25:1487-91.
11. Chin Y-H, Cai J-P, Xu X-M. Transforming growth factor-β1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes. J Imnunol 1992; 148:1106-12.
12. McGee DW, Beagley KW, Aicher WK, McGhee JR. Transforming growth factor-β and IL-1 act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 1993; 151:970-8.
13. Donnet-Hughes A, Schiffrin EJ, Huggett AC. Expression of MHC antigens by intestinal epithelial cells. Effects of transforming growth factor-beta 2. Clin Exp Immunol 1995; 99:240-4.
14. Planchon SM, Martins CAP, Guerrant RL, Roche JK. Regulation of intestinal epithelial barrier function by TGF-β1. J Immunol 1994; 153:5730-9.
15. Perr H, Oh P, Johnson D. Developmental regulation of transforming growth factor-β-mediated collagen synthesis in human intestinal muscle cells. Gastroenterol 1996; 110:92-101.
16. Ebert EC. Proliferative responses of human intraepithetial lymphocytes to various T cell stimuli. Gastroenterol 1989; 97:1372-81.
17. Roberts AI, O'Connell SM, Ebert EC. Intestinal intraepithelial lymphocytes bind to colon cancer cells by HML-1 and CD11a. Ca Research 1993; 53:1608-11.
18. Ebert EC, Roberts AI. Lymphokine-activated killing by human intestinal lymphocytes. Cell Immunol 1993; 146:107-16.
19. Takayama H, Trenn G, Sitkovsky MV. A novel cytotoxic T lymphocyte activation assay: optimized conditions for antigen receptor triggered granule enzyme secretion. J Immunol Methods 1987; 104:183-90.
20. Ignotz RA, Heino J, Massague J. Regulation of celt adhesion receptors by transforming growth factor-β: regulation of vitronectin receptor and LFA-1. J Biol Chem 1989; 264:389-92.
21. h2-like lymphokines by human T lymphocytes. Eur J Immunol 1992; 22:2173-6.
22. Espevik T, Waage A, Faxvage A, Shalaby MR. Regulation of interleukin-2 and interleukin-6 production from T cells: involvement of interleukin-1 and transforming growth factor-β. Cell Immunol 1990; 126:47.
23. Lotz M, Kekow J, Carson DA. Transforming growth factor-β and cellular immune responses in synovial fluids. J Immunol 1990; 144:4189-94.
24. Stoeck M, Ruegg C, Miescher S, Carrel S, Cox D, Van Fliedner V, Alkan S. Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors β1 and β2. J Immunol 1989; 143:3258-65.
25. + T cells by transforming growth factor-β1. J Immunol 1993; 151:668-77.
26. Lee H-M, Rich S. Co-stimulation of T cell proliferation by transforming growth factor-β1. J Immunol 1991; 147:1127-33.
27. Swain SL, Huston G, Tonkonogy S, Weinherg A. Transforming growth factor-β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991; 147:2991-3000.
28. 7 integrin. Nature 1994; 372:190-3.
29. + intestinal intraepithelial T lymphocytes have the characteristics of memory cells? Cell Immunol 1993; 147:331-40.
30. Lammers KM, Jansen J, Bijlsma PB et al. Polarized interleukin 8 secretion by HT29/19A cells. Gut 1994; 35:338-42.